Artigos

Search for articles

BJO Oncology - Placeholder

The Brazilian Journal of Oncology: a beacon of excellence in open access within the expanding universe of cancer research

The global landscape of cancer research has undergone a remarkable transformation in recent years. The increasing number of cancer cases worldwide(1) has fueled an unprecedented surge in cancer research publications.(2,3) This explosion of knowledge is underpinned by an equally significant shift towards open access publications, reflecting a commitment to making...
BJO Oncology - Placeholder

Littoral cell splenic angioma, a rare diagnosis of abdominal pain in a child: case report and literature review

ABSTRACT Littoral cell splenic angioma is a rare tumor, especially in the pediatric age group. Patients may experience mild chronic abdominal pain, that does not improve with usual treatments, and is mostly asymptomatic, a challenge for the pediatrics. This article describes the clinical features of a 10-year-old female pediatric patient...
BJO Oncology - Placeholder

Impact of advanced prostatic cancer treatment on quality of life and sexual function

ABSTRACT Introduction: The studying the quality of life after cancer treatment has become a priority in oncology. Objectives: To evaluate the impact of different treatments for recurrence prostate cancer on quality of life and sexual activity. Material and Methods: Two hundred patients with recurrence prostate cancer after initial treatment were...
BJO Oncology - Placeholder

Bioequivalence study between two formulations of 10mg lenalidomide capsules in healthy male subjects under fasting conditions

ABSTRACT Objective: To evaluate pharmaceutical bioequivalence between two formulations of 10mg lenalidomide capsules in healthy male subjects under fasting conditions. Material and Methods: An open label, monocentric, randomized, 2x2 crossover study in 32 healthy men under fasting conditions comparing two formulations of lenalidomide capsules. Analyte concentrations in human plasma were...
BJO Oncology - Placeholder

The average cost of treatment according to lung cancer stage using real-world data

ABSTRACT Introduction: Immunotherapy led to increased survival in advanced non-small cell lung cancer; however, it has also increased treatment costs. In this study, real-world data was used to evaluate the average cost of treatment of patients with lung cancer. Material and Methods: This is a retrospective study that extracted patient-level...
BJO Oncology - Placeholder

Sociodemographic effect on stage at diagnosis of melanoma patients treated in a public cancer center in Brazil

ABSTRACT Introduction: Melanoma is the most aggressive type of skin cancer, with a continuous increase in its incidence worldwide. The prognosis of patients is favorable, and the treatment is relatively simple and inexpensive when diagnosed at an early stage. However, early diagnosis requires easy access to the health system. In...
BJO Oncology - Placeholder

A 50-year-old male with oropharyngeal squamous cell carcinoma metastatic to hand soft tissue and bone - a case report

ABSTRACT A 50-year-old patient was referred to our service for the investigation of oropharynx cancer and was diagnosed with squamous cell carcinoma. Although there were no signs of distant metastasis, the disease was given as unresectable. The patient was treated with induction chemotherapy followed by chemoradiotherapy. After a trauma episode,...
BJO Oncology - Placeholder

The potential of telemedicine in alleviating out-of-pocket costs for oncological patients in the Brazilian public healthcare system

ABSTRACT Despite the absence of data regarding direct costs for healthcare, oncological patients from the Brazilian Unified Public Healthcare System often face significant financial burden due to out-of-pocket costs associated with their treatment. These costs include expenses for transportation, meals, non-covered medications, and the time spent on medical visits, tests,...
BJO Oncology - Placeholder

Uterine carcinosarcoma with microsatellite instability - does immunotherapy modify the therapeutic scenario? A case report and literature review

ABSTRACT Carcinosarcomas were reclassified by World Health Organization as high-grade uterine carcinomas in 2014. Due to its rare histology, comprising only 5% of uterine carcinomas, there is a small representation of this tumor in studies that evaluate metastatic uterine carcinomas treatment. In 2022, the treatment of metastatic uterine carcinomas has...
BJO Oncology - Placeholder

Evaluation of the impact of physical exercise on quality of life and clinical outcomes among women undergoing treatment for breast cancer

ABSTRACT To evaluate the association between the practice of physical exercises, quality of life and clinical outcomes in women diagnosed with and undergoing treatment for breast cancer. Cohort study, following-up women during 6 months after treatment beginning for breast cancer. A total of 149 participants were recruited for convenience in...